Axogen AXGN Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Axogen in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Axogen’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Axogen's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Axogen's cash & equivalents?
- Axogen (AXGN) reported cash & equivalents of $84.65M in Q1 2026.
- How has Axogen's cash & equivalents changed year-over-year?
- Axogen's cash & equivalents increased by 251.3% year-over-year, from $24.1M to $84.65M.
- What is the long-term trend for Axogen's cash & equivalents?
- Over 5 years (2020 to 2025), Axogen's cash & equivalents has grown at a -6.6% compound annual growth rate (CAGR), from $55.61M to $39.55M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.